ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results

ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results

ChromaDex (NASDAQ:CDXC – Get Free Report) released its earnings results on Thursday. The company reported $0.02 earnings per share for the quarter, Zacks reports. ChromaDex had a net margin of 1.62% and a return on equity of 5.06%. The firm had revenue of $25.58 million during the quarter, compared to the consensus estimate of $23.70 million. During the same period in the prior year, the firm earned ($0.01) EPS. ChromaDex updated its FY 2024 guidance to EPS.

ChromaDex Price Performance

Shares of NASDAQ:CDXC traded up $2.37 during trading on Friday, hitting $5.86. 37,543,352 shares of the company were exchanged, compared to its average volume of 264,220. ChromaDex has a 52-week low of $1.32 and a 52-week high of $5.98. The stock has a 50 day moving average of $3.53 and a 200 day moving average of $3.23. The company has a market cap of $444.95 million, a PE ratio of 586.59 and a beta of 1.88.

Insider Activity

In other news, Director Kristin Patrick sold 23,000 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $3.57, for a total transaction of $82,110.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 9.64% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 price target on shares of ChromaDex in a research report on Friday, August 9th.

ChromaDex Company Profile

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.

Share:
error: Content is protected !!